|
Isis Biopolymer, Inc. ("Isis") is an early stage, Rhode Island-based medical device company. Isis has developed a major advance in intelligent non-invasive drug delivery, the Isis Patch™. The Isis Patch is a personalized, single-use, flexible, ultra-thin, transdermal drug delivery ("TDD") patch. Isis is pioneering the emerging area of active TDD, which will allow medical professionals, for the first time, to accurately control transdermal drug delivery, ensuring reliable and effective drug administration over an extended period of time.
Founded in 2007, Isis is led by a veteran team of experienced entrepreneurs and scientists with deep expertise in medical devices, materials and systems design. Their breakthrough technology will greatly expand the current worldwide multi-billion dollar market for transdermal medications from the well-known nicotine and hormone patches into pain management, cancer therapeutics, neurology, diabetic medications and the treatment of many chronic and acute illnesses.
| 
